bioRxiv · 10.1101/2020.11.17.385096
The proteomic landscape of resting and activated CD4+ T cells reveal insights into cell differentiation and function
Abstract
CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells. The activation and functional status of CD4+ T cells is important for adequate responses to pathogen infections but has also been associated with auto-immune disorders and survival in several cancers. In the current study, we carried out a label-free high-resolution FTMS-based proteomic profiling of resting and T cell receptor-activated (72h) primary human CD4+ T cells from peripheral blood of healthy donors as well as SUP-T1 cells. We identified 5,237 proteins, of which significant alterations in the levels of 1,119 proteins were observed between resting and activated CD4+ T cells. We confirmed several known T-cell activation-related processes such as IL-2 response, metabolic and signaling changes, cell cycle induction, differentiation into effector cells among others. Several stimulatory/inhibitory immune checkpoint markers were altered considerably between resting and activated CD4+ T cells. Network analysis identified several known regulatory hubs of CD4+ T cell activation, including IFNG, IRF1, FOXP3, AURKA, and novel hubs such as RIOK2. Comparison of primary CD4+ T cell proteomic profiles with human lymphoblastic cell lines revealed a substantial overlap, while comparison with mouse CD+ T cell data suggested interspecies proteomic differences.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Subbannayya, Y., Haug, M., Pinto, S., Mohanty, V., Meas, H. Z., Prasad, T. S. K., Flo, T. H., Kandasamy, R. K.. 2020-11-17. The proteomic landscape of resting and activated CD4+ T cells reveal insights into cell differentiation and function. https://doi.org/10.1101/2020.11.17.385096
Cite the original work for its findings. Save a collection to share your selection of sources.